Biblio
Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs. Drug Dev Res. 2023.
. Predominant factors influencing reactive oxygen species in cancer stem cells. J Cell Biochem. 2023.
. Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt β-catenin pathway, disrupting the interaction between β-catenin and CD24 and suppressing autophagy. Life Sci. 2023:121384.
. Want of Wnt in Parkinson's disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?. Biochem Pharmacol. 2023:115566.
. Wnt Antagonist as therapeutic targets in Ovarian Cancer. Int J Biochem Cell Biol. 2022:106191.
. .
Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sci. 2020:118854.
. Pigment epithelium-derived factor regulation of neuronal and stem cell fate. Exp Cell Res. 2020:111891.
. Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells: Concise review. Stem Cells. 2019.
. . . Multi-lineage differentiation of mesenchymal stem cells - To Wnt, or not Wnt. Int J Biochem Cell Biol. 2015.
. . .